Skip to main content

Genotypic characteristics of Staphylococcus aureus isolates from a multinational trial of complicated skin and skin structure infections.

Publication ,  Journal Article
Campbell, SJ; Deshmukh, HS; Nelson, CL; Bae, I-G; Stryjewski, ME; Federspiel, JJ; Tonthat, GT; Rude, TH; Barriere, SL; Corey, R; Fowler, VG
Published in: J Clin Microbiol
February 2008

The impact of bacterial genetic characteristics on the outcome of patients with Staphylococcus aureus infections is uncertain. This investigation evaluated potential associations between bacterial genotype and clinical outcome using isolates collected as part of an international phase 2 clinical trial (FAST II) evaluating telavancin for the treatment of complicated skin and skin structure infections (cSSSI). Ninety S. aureus isolates from microbiologically evaluable patients with cSSSI enrolled in the FAST II trial from 11 sites in the United States (56 isolates, or 62%) and 7 sites in South Africa (34 isolates, or 38%) were examined for staphylococcal cassette chromosome mec, agr, and the presence of 31 virulence genes and subjected to pulsed-field gel electrophoresis (PFGE). South African methicillin-susceptible S. aureus (MSSA) isolates were more likely to carry certain virulence genes, including sdrD (P = 0.01), sea (P < 0.01), and pvl (P = 0.01). All 44 (49%) methicillin-resistant S. aureus (MRSA) isolates were from the United States; 37 (84%) were strain USA 300 by PFGE. In the United States, MRSA isolates were more likely than MSSA isolates to carry genes for sdrC (P = 0.03), map/eap (P = 0.05), fnbB (P = 0.11), tst (P = 0.02), sea (P = 0.04), sed (P = 0.04), seg (P = 0.11), sej (P = 0.11), agr (P = 0.09), V8 (P = 0.06), sdrD, sdrE, eta, etb, and see (P < 0.01 for all). MRSA isolates were more often clonal than MSSA isolates by PFGE. Isolates from patients who were cured were significantly more likely to contain the pvl gene than isolates from patients that failed or had indeterminate outcomes (79/84 [94%] versus 3/6 [50%]; P = 0.01). S. aureus strains from different geographic regions have different distributions of virulence genes.

Duke Scholars

Published In

J Clin Microbiol

DOI

EISSN

1098-660X

Publication Date

February 2008

Volume

46

Issue

2

Start / End Page

678 / 684

Location

United States

Related Subject Headings

  • Virulence Factors
  • United States
  • Treatment Outcome
  • Trans-Activators
  • Staphylococcus aureus
  • Staphylococcal Skin Infections
  • South Africa
  • Penicillin-Binding Proteins
  • Molecular Epidemiology
  • Middle Aged
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Campbell, S. J., Deshmukh, H. S., Nelson, C. L., Bae, I.-G., Stryjewski, M. E., Federspiel, J. J., … Fowler, V. G. (2008). Genotypic characteristics of Staphylococcus aureus isolates from a multinational trial of complicated skin and skin structure infections. J Clin Microbiol, 46(2), 678–684. https://doi.org/10.1128/JCM.01822-07
Campbell, Steven J., Hitesh S. Deshmukh, Charlotte L. Nelson, In-Gyu Bae, Martin E. Stryjewski, Jerome J. Federspiel, Giang T. Tonthat, et al. “Genotypic characteristics of Staphylococcus aureus isolates from a multinational trial of complicated skin and skin structure infections.J Clin Microbiol 46, no. 2 (February 2008): 678–84. https://doi.org/10.1128/JCM.01822-07.
Campbell SJ, Deshmukh HS, Nelson CL, Bae I-G, Stryjewski ME, Federspiel JJ, et al. Genotypic characteristics of Staphylococcus aureus isolates from a multinational trial of complicated skin and skin structure infections. J Clin Microbiol. 2008 Feb;46(2):678–84.
Campbell, Steven J., et al. “Genotypic characteristics of Staphylococcus aureus isolates from a multinational trial of complicated skin and skin structure infections.J Clin Microbiol, vol. 46, no. 2, Feb. 2008, pp. 678–84. Pubmed, doi:10.1128/JCM.01822-07.
Campbell SJ, Deshmukh HS, Nelson CL, Bae I-G, Stryjewski ME, Federspiel JJ, Tonthat GT, Rude TH, Barriere SL, Corey R, Fowler VG. Genotypic characteristics of Staphylococcus aureus isolates from a multinational trial of complicated skin and skin structure infections. J Clin Microbiol. 2008 Feb;46(2):678–684.

Published In

J Clin Microbiol

DOI

EISSN

1098-660X

Publication Date

February 2008

Volume

46

Issue

2

Start / End Page

678 / 684

Location

United States

Related Subject Headings

  • Virulence Factors
  • United States
  • Treatment Outcome
  • Trans-Activators
  • Staphylococcus aureus
  • Staphylococcal Skin Infections
  • South Africa
  • Penicillin-Binding Proteins
  • Molecular Epidemiology
  • Middle Aged